HCW Biologics Inc. - Common Stock (HCWB)
0.2697
-0.0051 (-1.86%)
Hcw Biologics Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cancer and immune-related diseases
The company's pipeline includes a range of biologic products that harness the body's immune system to target and destroy cancer cells, aiming to improve patient outcomes and enhance the quality of life for those affected by such conditions. Through advanced research and development, Hcw Biologics is committed to addressing significant medical needs in the oncology space and advancing personalized medicine.
